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The mitochondrial phosphate carrier (PiC) of mammals, but not the yeast one, is 
synthesized with a presequence.  The deletion of this presequence of the mammalian 
PiC was reported to facilitate the import of the carrier into yeast mitochondria, but the 
question as to whether or not mammalian PiC could be functionally expressed in yeast 
mitochondria was not addressed.  In the present study, we first examined whether the 
defective growth on a glycerol plate of yeast cells lacking the yeast PiC gene could be 
reversed by the introduction of expression vectors of rat PiCs.  The introduction of 
expression vectors encoding full-length rat PiC (rPiC) or rPiC lacking the presequence 
(ΔNrPiC) was ineffective in restoring growth on the glycerol plates.  When we 
examined the expression levels of individual rPiCs in yeast mitochondria, ΔNrPiC was 
expressed at a level similar to that of yeast PiC, but that of rPiC was very low.  These 
results indicated that ΔNrPiC expressed in yeast mitochondria is inert.  Next, we 
sought to isolate “revertants” viable on the glycerol plate by expressing randomly 
mutated ΔNrPiC, and obtained two clones.  These clones carried either of two 
mutations, F267S or F282S; and these mutations restored the transport function of 
ΔNrPiC in yeast mitochondria.  These two Phe residues were conserved in human 
carrier (hPiC), and the transport function of ΔNhPiC expressed in yeast mitochondria 
was also markedly improved by their substitutions.  Thus, substitution of F267S or 
F282S was concluded to be important for functional expression of mammalian PiCs in 





Mitochondrial ATP synthesis is achieved in the matrix space owing to the 
electrochemical gradient of H
+
 across the mitochondrial inner membrane acting as a 
driving force.  To enable efficient ATP synthesis, the mitochondrial inner membrane 
shows high resistance against the permeation of molecules.  However, numbers of 
molecular species involved in biochemical reactions such as ATP synthesis, β-oxidation 
or TCA cycle must be transported into the matrix space of mitochondria.  The transport 
of individual molecule species is catalyzed by their specific transport proteins.  These 
transporters show structural similarities with each other and are thought to have been 
formed from a common ancestral gene; and, hence, they are referred to as members of 
the mitochondrial solute carrier family, SLC25a (For reviews, see refs. 1-5).   
Most carrier proteins have been conserved in both yeast and mammals.  As 
manipulation of the yeast genome is much easier than that of the mammalian one, yeast 
would seem to be very useful for structure/function studies on mammalian 
mitochondrial solute carriers.  Actually, numbers of yeast mitochondrial carriers such 
as Sam5p, Flx1p, Oac1p, Leu5p, Rim2p, Ort1p, and Crc1p have been successfully 
complemented by the human orthologs SLC25A26 [6], SLC25A32 [7], SLC25A34 [8], 
SLC25A42 [9], SLC25A33 and SLC25A36 [10], SLC25A15 [11, 12], and SLC25A20 
[13].  However, complementation of yeast mitochondrial carriers by their mammalian 
ortholog is not always successfully achieved.  In the case of the mitochondrial 
ADP/ATP carrier, introduction of the expression vector of the native bovine carrier into 
yeast cells lacking a functional ADP/ATP carrier gene was not effective in rescuing 
them from their defect in ATP synthesis, indicating that the native bovine carrier cannot 
be functionally expressed in yeast mitochondria [14].  As the yeast carrier has a longer 
N-terminal sequence than the bovine one, we examined earlier whether it would be 
possible to express a chimeric bovine carrier whose N-terminal sequence had been 
substituted with the corresponding region of the yeast carrier and found that this was the 
case [14].  Not only the bovine carrier but also the human one could be functionally 
expressed in yeast cells as chimeric proteins [15].    
In the case of the mitochondrial phosphate carrier (PiC), the mammalian one, but not 
the yeast one, is synthesized with a presequence, which is cleaved at the mitochondria 
[16-18].  Furthermore, an earlier study clearly demonstrated that deletion of the 
presequence of the mammalian mitochondrial phosphate carrier facilitates the import of 
the carrier into yeast mitochondria [19].  However, the more intriguing question of 
whether or not the mammalian phosphate carrier can be expressed in a functional form 
in yeast mitochondria had not been addressed.  Therefore, in the present study we 
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examined whether the mammalian mitochondrial phosphate carrier could be 
functionally expressed in yeast cells.   
 
 
2. Materials and Methods  
 
2.1. Materials  
The haploid strain of Saccharomyces cerevisiae W303-1B (MATα ade2-1 leu2-3, 112 
his3-22,15 trp1-1 ura3-1 can1-100) was used as the wild type [14].  The single- and 
multi-copy type expression vectors in yeast cells were prepared by introducing the 
promoter region of the yeast type 2 ADP/ATP carrier gene into pRS314 and pYO326, 
respectively, as described previously [14].  Antibody against the FLAG tag (code 
F7425-2MG) was purchased from Sigma-Aldrich.   
 
2.2. Preparation of a yeast strain lacking its MIR1 gene (mir1Δ)   
Disruption of the MIR1 gene encoding the mitochondrial phosphate carrier in the 
W303-1B strain was achieved by homologous recombination (mir1::HIS3).  The 
structure of the targeting construct used for disruption of the MIR1 gene is shown in 
Supplementary Fig. S1a.  This construct was prepared by PCR.  Briefly, the first 
PCR was carried out by using GE2857 and GE2859 as primers, and pRS313 as a 
template, as shown in Supplementary Fig. S1b.  The nucleotide sequences of 
one-third of the 3’ side of these two primers corresponded to those at the 5' and 3' 
regions of the HIS3 gene, respectively, in the pRS313; and the nucleotide sequences of 
their remaining regions corresponded to those at the 5’ and 3’ regions of the MIR1 gene 
of the yeast genome.  The second PCR was carried out by using GE2858 and 2860 as 
primers, and the PCR product of the first reaction as a template.  Actual nucleotide 
sequences of individual primers are shown in Supplementary Fig. S1c.  The 
nucleotide sequences of GE2857 and GE2859, shown in green, are those that annealed 
to the HIS3 gene; and the boxed nucleotide sequences represent overlapped sequences 
between primers GE2857 and GE2858, and those between primers GE2859 and 
GE2860.  The resultant PCR product was gel purified and used for transformation.   
 
2.3. Preparation of cDNA and expression vectors of yeast, rat, and human 
mitochondrial phosphate carriers (abbreviated as yPiC, rPiC, and hPiC, respectively), 
and their mutants   
The cDNA fragments encoding yPiC, rPiC, and hPiC were prepared by RT-PCR or PCR.  
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Strategies for PCR, template DNA, and nucleotide primers used for preparation of these 
cDNA fragments are summarized in Supplementary Table SI.  These cDNA 
fragments were subcloned into single copy-type (pRS314) or multi copy-type (pYO326) 
expression vectors having the promoter region of the yeast type 2 ADP/ATP carrier gene 
(referred to as pRS314/yA2P and pYO326/yA2P, respectively).  The methods used for 
preparation of expression vectors of PiCs having a C-terminal FLAG tag are 
summarized in Supplementary Fig. S2.     
 
2.4. Observation of cell growth   
To examine the growth-defect phenotype, we streaked a yeast cell suspension on agar 
plates containing 1% yeast extract, 2% bactopeptone, and 2% agar supplemented with 
either 2% glucose (YPD) or 3% glycerol (YPGly) as a carbon source.  After incubation 
at 30° C for 2 or 5 days, the cell growth was assessed photographically.    
 
2.5 Preparation of mitochondrial fraction from cultured yeast cells and Western blotting  
For preparation of mitochondria, yeast cells were cultured in a liquid medium 
containing 1% yeast extract, 2% bactopeptone, and 2% galactose at 30° C.  The 
mitochondria fraction was prepared as described previously [20].   
Western blotting was performed as described earlier [20,21].  Samples of 20 μg (for 
detection of FLAG-tagged PiC) or 5 μg (for Por1p) aliquots of mitochondrial fractions 
were subjected to SDS-PAGE and subsequent Western blotting, and PiCs having the 
FLAG tag were detected by use of anti-FLAG antibody.  Yeast Por1p (mitochondrial 
porin, also referred to as voltage-dependent anion channel) was also detected as a 
control by using anti-Por1p antibody, which was raised in a rabbit immunized with a 
synthetic peptide with the amino acid sequence of IVGGAEFGYDISAGSISRYC 
(amino acids 147 – 165 of yeast Por1p (NM_001182894) plus a C-terminal Cys residue 
for conjugation with hemocyanin) as the immunogen.   
To ascertain the proper preparation of the mitochondrial fraction from yeast cells, we 
subjected a whole cell lysate and mitochondrial fraction to Western blotting by using 
antibodies against FLAG tag, Por1p, and glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH).  Results obtained from mir1Δ and that expressing yPiC are shown in 
Supplementary Fig. S3.   
 
2.6. Identification of amino acids important for functional expression of rPiC by 
PCR-based random mutation and gap-repair cloning   
The outline of the PCR-based random mutation and gap-repair cloning procedure is 
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depicted in Supplementary Fig. S4.   
The randomly mutated cDNA fragments corresponding to the open reading frame of rat 
PiC lacking its N-terminal presequence (ΔNrPiC-A) were obtained by PCR using Taq 
DNA polymerase, because it is well known that mutation of DNA will occur at a certain 
frequency during ordinary PCR using this polymerase [22].  The amplification 
conditions used (25 μl) consisted of 0.2 ng template DNA (pYO326/yA2p/ΔNrPiC-A), 
25 pmol each of primers (GE2046, 5’-GTAATACGACTCACTATAG and GE2047, 
5’-TACAAGTCAAAGGAGCCCC), 1 × HY buffer, 200 μM dNTP, and 1.25 units of 
Taq DNA polymerase (Greiner, code 986007).  The mixture was heated at 95° C for 5 
min and then subjected to a chain reaction of 35 cycles of heating at 95° C for 30 sec, 
56° C for 30 sec, and 72° C for 1 min, with a final extension at 72° C for 15 min.   
The resulting amplification mixture was mixed with 10 μg aliquots of the expression 
vector of ΔNrPiC (rPiC lacking its N-terminal presequence) digested with BamHI and 
BglII.  Then, the yeast cells lacking their MIR1 gene were transformed with the above 
mentioned mixture, and spread on an agarose plate containing minimum medium with 
glycerol as a carbon source but lacking uracil and histidine.  After 10 days’ incubation 
at 30° C, two viable colonies on the plate were obtained.   
 
2.7. Measurement of phosphate transport function of PiCs expressed in yeast 
mitochondria  
The phosphate transport function of the expressed protein was evaluated either by 
measuring the turbidity change in the mitochondrial suspension or by measuring the 
uptake of [
32
P]phosphate [23].  As for the former, mitochondria (0.25 mg protein) 
prepared from individual transformant yeast cells were suspended in 1.5 ml of medium 
containing 120 mM ammonium chloride or 120 mM ammonium phosphate, 20 mM Tris 
(pH 7.4), 1 mM EDTA, and 5 mM rotenone; and time-dependent absorbance changes in 
the suspension at 546 nm were recorded by use of a Shimadzu spectrophotometer, 
model UV-1800.  As for the latter evaluation, mitochondria (0.25 mg of protein) were 
incubated at 0° C in a medium consisting of 20 mM Tris-Cl, pH 6.5, 100 mM KCl, 1 
mM EGTA, 1 μg/ml rotenone, and 20 mM butylmalonate.  The uptake was started by 
adding 1.35 mM [
32
P]phosphate, and after incubation for 20 sec, terminated by the 
addition of 1.5 mM mersalyl.  The amount of [
32
P]phosphate specifically taken up by 
mitochondria was corrected by subtracting the radioactivity observed with mitochondria 





3. Results  
 
3.1. Preparation for the experiments evaluating functional expression of rat PiC in yeast 
cells  
Past studies demonstrated that disruption of the gene encoding the yeast mitochondrial 
phosphate carrier causes a growth-defect phenotype of yeast grown on plates containing 
glycerol as a sole carbon source [24, 25] and that this growth defect can be reversed by 
introduction of an expression vector encoding the yeast phosphate carrier [25].  We 
also observed the growth-defect phenotype of a yeast strain lacking a functional 
phosphate carrier gene, MIR1 (mir1Δ), on a glycerol plate, and its rescue by 
introduction of an expression vector for the yeast mitochondrial phosphate carrier (see 
Supplementary Fig. S1d).  Thus, this experimental system was successfully 
confirmed.    
We next prepared the expression vectors for the rat mitochondrial phosphate carrier for 
introduction into yeast cells.  The reason for choosing rat as an animal species is 
because functional studies on mitochondria have been mainly carried out by using 
mitochondria isolated from rat liver.  In this manuscript, PiCs of yeast and rat are 
referred to as yPiC and rPiC, respectively.   
As for the mammalian mitochondrial phosphate carrier, two splice variants, referred to 
as PiC-A and PiC-B, respectively, generated by alternative use of exons 3A and 3B, are 
known to be expressed (see Fig. 1a and ref. [18]).  Thus, the entire cDNAs encoding 
the full-length form of these two variants of rat PiCs were prepared by RT-PCR.  
Because PiC-A is reported to be expressed in the heart and skeletal muscle, and PiC-B 
is ubiquitously expressed [26,27], first-strand cDNAs prepared from total RNA of rat 
heart were used as templates for preparation of rPiC-A; and those from rat brain, for 
preparation of rPiC-B.  After confirmation of the proper nucleotide sequence of 
individual cDNAs, they were subcloned into the expression vector pYO326/yA2P [14].   
We also prepared expression vectors of rPiC-A and rPiC-B lacking their presequence 
(designated as ΔNrPiC-A and ΔNrPiC-B, respectively; see also Figs. 1b and 1c), 
because a past study clearly demonstrated that the deletion of the presequence of the 
mammalian PiC facilitates the import of the carrier into yeast mitochondria [19].  
Totally, 4 expression vectors of A and B isoforms of rPiCs (rPiC-A and rPiC-B) and the 
precursor/mature forms containing/lacking their presequence (rPiC and ΔNrPiC) were 
prepared.   
 
3.2. The growth of the mir1Δ cells on the glycerol plate was not recovered by 
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introduction of expression vectors of rat PiCs  
When we transformed mir1Δ cells with the expression vector for the full-length open 
reading frame of either rPiC-A or rPiC-B, the yeast with the disrupted phosphate carrier 
were not rescued from their growth defect on the glycerol plate (Fig. 2a), indicating the 
failure of the functional expression of rPiC in yeast mitochondria by using these vectors.  
Unexpectedly, mir1Δ cells transformed with the expression vector for either ΔNrPiC-A 
or ΔNrPiC-B were also unable to grow on the glycerol plate (Fig. 2a).   
 
3.3. Evaluation of the expression levels of the rPiC in yeast mitochondria   
In the above experiments, if the growth defect of the mir1Δ cells on the glycerol plate 
had been successfully rescued by the introduction of an expression vector, this result 
would have reflected the functional expression of the rPiC encoded by the introduced 
expression vector.  However, as rescue was not achieved by this means, this result 
might be attributed to i) failure in proper expression of the rPiC in yeast mitochondria or 
ii) lack of the transport function of the expressed rPiC.  To ascertain which of these 
two possibilities was the case, we next examined the expression levels of rPiC in yeast 
mitochondria.   
For this purpose, we prepared expression vectors of PiC/FLAG, each having a flanking 
sequence of the FLAG tag at its C-terminal end (4 rPiCs and yPiC, totally 5 PiCs).  
When we transformed the mir1Δ cells with any of these expression vectors, the 
transformants showed phenotypes similar to those observed for the cells transformed 
with the expression vector not having the FLAG tag (Supplementary Fig. S5), 
suggesting that the addition of the FLAG tag at their C-terminal end did not affect the 
function of the individual rPiC.   
When we prepared the mitochondrial fraction from the transformed yeast cells and 
subjected them to SDS gel electrophoresis and subsequent Western analysis using 
anti-FLAG antibody, we observed strong immunoreactive protein bands for 
mitochondrial fractions obtained from the cells transformed with the expression vector 
encoding yPiC/FLAG or type A or type B isoforms of ΔNrPiC/FLAG, as shown in Fig. 
2b.  These results clearly demonstrated that type A or type B isoforms of ΔNrPiC were 
well expressed at the mitochondrial membrane, as was yPiC.   
Interestingly, moreover, mitochondrial fractions from yeast cells transformed with the 
expression vector encoding type A or type B isoforms of rPiC/FLAG also showed a 
faint immunoreactive protein band having slower migration than that of yPiC/FLAG or 
type A or type B isoforms of ΔNrPiC/FLAG (Fig. 2b).  This result might indicate that 
a small amount of full-length rat PiC with its presequence could also be expressed at the 
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mitochondrial membrane.   
These data clearly demonstrated that rPiC lacking its presequence, i.e., ΔNrPiC, could 
be more effectively expressed than its full-length form (rPiC), in yeast mitochondria, in 
accordance with the results reported earlier [19]; and this property was consistently 
observed with rPiCs regardless of differences in isoform type  (type A or B).   
More importantly, it was evident that presequence-depleted forms of rPiC, i.e., 
ΔNrPiC-A or ΔNrPiC-B, were well expressed in yeast mitochondria; although mir1Δ 
cells transformed with expression vectors for these proteins failed to grow on a glycerol 
plate, indicating the lack of transport activity of ΔNrPiC expressed in yeast 
mitochondria.   
 
3.4. Isolation of revertants viable on the glycerol plate by PCR-mediated random 
mutation and gap-repair cloning 
Then the question arose as to why ΔNrPiC was inactive in yeast mitochondria.  To 
answer to this question, we sought to isolate “revertants” viable on glycerol plates.  As 
the above results clearly indicated that two splice variants of rPiC-A and rPiC-B showed 
essentially the same results, the following experiments were achieved using rPiC-A 
variants.  Also, hereafter, rPiC-A and ΔNrPiC-A, will be simply referred to as rPiC and 
ΔNrPiC, respectively.   
For screening of yeast cells in which randomly mutated ΔNrPiC was expressed, we 
employed the techniques of “PCR-mediated random mutation” and “gap-repair cloning” 
(for details, see Methods, Supplementary Fig. S4 and ref. 28).  When yeast cells 
lacking the MIR1 gene (mir1Δ) were incubated with a mixture of randomly mutated 
DNA fragments encoding ΔNrPiC and an expression vector digested with BglII and 
BamHI, and spread onto a selective agarose plate (agarose plate with minimum medium 
containing glycerol as a carbon source but lacking uracil and histidine), only two viable 
colonies were obtained (i.e., the total number of clones obtained with the above 
mentioned strategy was 2).  When plasmid vectors in these colonies were subjected to 
sequence analysis, these expression vectors in both colonies were found to carry a 
distinct mutation of F267S or F282S in their rPiC (these two Phe residues are 
highlighted in blue in Fig. 1c).  To confirm whether one of these mutations had 
enabled the growth of the mir1Δ cells on the glycerol plate, yeast cells lacking the MIR1 
gene were transformed with each expression vector of ΔNrPiC having one of these 
mutations; and their growth on the glycerol plate was then examined.  As a result, 
either mutation effectively enabled the growth of the mir1Δ cells on the glycerol plate 
(Fig. 3a).  These two colonies carrying the F267S or F282S mutation, obtained by 
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PCR-mediated random mutation and gap-repair cloning from the pre-sequence-depleted 
background (i.e., ΔNrPiC), will hereafter be referred to as ΔNrPiC (F267S) and ΔNrPiC 
(F282S), respectively.   
 
3.5. Characterization of ΔNrPiC (F267S) and ΔNrPiC (F282S) mutants 
To characterize these two mutants, ΔNrPiC (F267S) and ΔNrPiC (F282S), we further 
conducted two experiments.  First, we roughly examined the differences in the growth 
rates of the yeast cells expressing these mutants with those of mir1Δ cells and mir1Δ 
cells expressing yPiC, rPiC or ΔNrPiC.  For this examination, culture suspensions of 
individual yeast cells were serially diluted and spotted on YPGly plates; and after 
incubation at 30° C for 3 days, the growth of individual yeast cells was compared.  As 
a result, as shown in Fig. 3b, the degree of cell growth was in the order of yeast cells 
expressing yPiC > ΔNrPiC (F282S) > ΔNrPiC (F267S); and the growth of mir1Δ cells 
or mir1Δ cells transformed with expression vectors of rPiC or ΔNrPiC was not observed.  
However, it was difficult to ascertain whether the differences in the observed growth 
were due to differences in their expression levels or due to differences in the 
functionality of the expressed proteins.  Thus, we conducted a second experiment to 
evaluate the expression levels of the individual proteins.  For this purpose, we 
constructed expression vectors of individual mutants having a C-terminal FLAG tag, as 
described above (Fig. 2b).  As shown in Fig. 3c, the signal intensities of the 
immunoreactive protein band observed with mitochondria fractions prepared from yeast 
cells expressing ΔNrPiC (F267S)/FLAG or ΔNrPiC (F282S)/FLAG were not markedly 
different from that intensity observed with ΔNrPiC/FLAG.  Thus, the effects of these 
mutations on the growth of the mir1Δ on the glycerol plate were concluded to reflect the 
improved functionality of the expressed proteins.  It should be noted that the migration 
of ΔNrPiC (F267S)/FLAG or ΔNrPiC (F282S)/FLAG in the polyacrylamide gel was 
slightly slower than that of ΔNrPiC/FLAG.  The exact reason causing changes in the 
degree of migration in the polyacrylamide gel by this point mutation is uncertain, but it 
seems not to be such a rare case; because we have observed a similar phenomenon with 
the mitochondrial voltage-dependent anion channel (VDAC) [29].   
 
3.6. Measurement of the phosphate transport function of the mutant rPiCs expressed in 
yeast mitochondria  
To confirm the effects of a mutation in ΔNrPiC on its transport function, we further 
assessed the transport activity of the PiC expressed in yeast mitochondria.  Toward this 
end, we prepared mitochondria from individual transformants and subjected them to 
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swelling in either an NH4Cl or NH4Pi solution [23].  As shown in Fig. 4a, 
mitochondria prepared from mir1Δ cells showed no remarkable difference in the 
swelling in these two solutions; whereas those prepared from yeast cells expressing 
yPiC swelled more significantly in the NH4Pi solution than in the NH4Cl solution, 
reflecting functional phosphate transport in the latter mitochondria.  Mitochondria 
prepared from yeast cells expressing ΔNrPiC also showed no remarkable difference in 
the swelling in either solution, but those from cells expressing ΔNrPiC (F267S) or 
ΔNrPiC (F282S) showed stronger swelling in the NH4Pi solution than in the NH4Cl one.  
These results clearly validated our conclusion that ΔNrPiC (F267S) or ΔNrPiC (F282S) 
but not ΔNrPiC showed the phosphate transport activity.    
We also evaluated the transport function of individual carrier proteins by direct 
measurement of the phosphate uptake by using [
32
P]phosphate as a tracer, and obtained 
essentially the same results, as shown in Fig. 4b, as those observed with the swelling 
experiments.    
Ideally, it would be possible to demonstrate a difference in sensitivities of mammalian 
and yeast mitochondrial phosphate carriers to N-ethylmaleimide (NEM) [30,31] by 
using mitochondria prepared from yeast cells expressing yPiC and ΔNrPiC (F267S) or 
ΔNrPiC (F282S).  We succeeded in observing the inhibition of both mammalian and 
yeast mitochondrial phosphate carriers by exposing the mitochondria to higher 
concentrations of NEM (data not shown), but trials to demonstrate a difference in 
sensitivities of mammalian and yeast mitochondrial phosphate carriers to NEM were not 
successful, due to the difficulties in adjusting the proper experimental conditions to 
demonstrate such a difference, because sufficient amounts of mitochondria with high 
purity would be required.   
 
3.7. Depletion of presequence and amino acid substitution were also effective in the 
functional expression of human PiC in yeast mitochondria  
The above results clearly indicated that depletion of the presequence was essential for 
expression of rat PiC in yeast mitochondria, but ΔNrPiC thus expressed was inactive, 
and that further substitution of F267 or F282 with Ser was necessary for restoring the 
transport function of the expressed ΔNrPiC in yeast mitochondria.  We next tested 
whether depletion of the presequence and amino acid substitution were also effective in 
the functional expression of human PiC in yeast mitochondria.   
As two splice variants of hPiC, i.e., hPiC-A and hPiC-B, showed essentially the same 
properties (data not shown) as observed with rPiCs (Fig. 2), we conducted the following 
studies using the hPiC-A variant, and hPiC-A and ΔNhPiC-A will hereafter be simply 
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referred to as hPiC and ΔNhPiC, respectively.  
When we compared the growth of yeast cells expressing full-length human PiC (hPiC), 
its presequence-depleted form (ΔNhPiC), and yPiC on the glycerol plate, cells 
expressing hPiC failed to grow.  The yeast cells expressing ΔNhPiC showed slight 
growth, but its level was almost negligible in comparison with that of cells expressing 
yPiC (Fig. 5).  Substitution of either F267 or F282 in ΔNhPiC with Ser caused 
remarkable acceleration of the growth rate of the host cells, to a level of growth 
comparable to that of the yPiC transformant.   
Thus, mutations of these Phe residues to Ser ones were concluded be effective for 
functional expression of not only rat PiC but also human PiC.  The introduction of the 
mutated (F267S or F282S) hPiC expression vector harboring its presequence into the 
mir1Δ cells also slightly accelerated the growth of these cells on the glycerol plate, but 
this effect was negligible.  Thus, in addition to the depletion of the presequence, the 
substitution of F267 or F282 with Ser was concluded to be effective for functional 
expression of not only rat PiC but also human PiC in yeast cells.   
 
3.8. Further substitution studies on the amino acids of yPiC and mammalian PiC  
To explore a possible reason why substitution of F267S or F282S of mammalian PiC 
was effective in restoration of their function in yeast cells, we further conducted two 
experiments.  The first experiment involved reverse substitution of P274 or G289 of 
yPiC, corresponding to F267 or F282 of ΔNrPiC or ΔNhPiC, respectively, with Phe.  
As shown in Fig. 6a, yeast cells expressing yPiC (P274F) or yPiC (G289F) grew well 
on the glycerol plate, indicating that a Phe residue at these positions was not inhibitory 
for the function of yPiC.  In the second experiment we examined the effect of 
substitution of the Phe residue of the mammalian PiC with amino acids other than Ser.  
This experiment was conducted with the F282 residue of ΔNrPiC.  As shown in Fig. 
6b, yeast cells expressing ΔNhPiC of which F282 was substituted with a basic (F282K) 
or acidic (F282E) or hydrophobic (F282L) residue failed to grow, but those substituted 
with Thr or Gly grew slightly.   
 
 
4. Discussion  
An earlier study clearly demonstrated that deletion of the presequence of the 
mammalian mitochondrial phosphate carrier facilitates the import of the carrier into 
yeast mitochondria [19].  In the present study, we addressed the more intriguing 
question of whether the mammalian phosphate carrier could be expressed in a functional 
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form in yeast mitochondria.  For this purpose, we first examined whether the 
growth-defect phenotype of a yeast strain lacking a functional phosphate carrier gene, 
MIR1 (mir1Δ), on a glycerol plate could be rescued by introduction of an expression 
vector of rPiC.  The introduction of expression vectors encoding neither full-length rat 
PiC (rPiC) nor rat PiC lacking its presequence (ΔNrPiC) was effective in rescuing 
mir1Δ cells from their growth defect.  To understand the reason for this ineffectiveness, 
we further examined the expression levels of individual proteins.  As a result, the 
presequence-depleted form (ΔNrPiC), but not the full-length form (rPiC), was well 
expressed at the mitochondrial membrane, as was yPiC (Fig. 2).  Thus, the 
presequence-depletion effects of the mammalian PiC on the effective sorting of PiC into 
yeast mitochondria [19] were clearly reconfirmed in the present study.  In addition, 
these results clearly indicated that ΔNrPiC expressed in yeast mitochondria was inert.   
Thus, we next considered the reason as to why it was inert.  To address this issue, by 
expressing mutated ΔNrPiC in mir1Δ cells, we sought to isolate “revertants” that would 
be viable on the glycerol plate.  For such a purpose, mutagenesis by ethyl 
methanesulfonate has been employed [32,33].  However, this procedure induces 
non-selective mutations in the genome; and hence, higher efforts are required for 
identification of the mutation responsible for the functional expression of the target 
carrier.  In the present study, we employed the strategy combining the “PCR-mediated 
random mutation” and “gap-repair cloning”.  The use of this strategy seems to have the 
great advantage of avoiding the side effects, i.e., “off target effects”.  Actually, in the 
present study, we obtained only two colonies; and both carried effective mutations 
responsible for the functional expression of ΔNrPiC in yeast mitochondria.  Thus, the 
use of this strategy combining the “PCR-mediated random mutation” and “gap-repair 
cloning” procedures was proven to be quite effective for identification of the amino acid 
residues responsible for the functional expression of the mitochondrial phosphate 
carrier.   
With these experiments, we succeeded in clearly demonstrating the restorative effect of 
the mutation F267S or F282S in ΔNrPiC on its transport function.  Interestingly, the 
amino acid residues F267 and F282 were conserved in hPiC.  Thus, we next conducted 
an experiment to determine whether these mutations would also be effective in the 
functional expression of the hPiC.  The mir1Δ cells transformed with expression vector 
encoding hPiC failed to grow on a glycerol plate, as in the case of those transformed 
with expression vectors of rPiCs; whereas those transformed with the ΔNhPiC 
expression vector grew slightly (Fig. 5).  Mutation of F267S or F282S in ΔNhPiC 
significantly improved the growth of the transformant, and this result clearly indicated 
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that either mutation was also effective in restoring the transport activity of ΔNhPiC 
expressed in yeast mitochondria.  The reason why mir1Δ cells transformed with the 
ΔNhPiC expression vector could grow slightly on a glycerol plate, distinct from cells 
transformed with the expression vector encoding ΔNrPiC, is uncertain.  The 16 amino 
acid residues not conserved between ΔNrPiC and ΔNhPiC could be responsible for the 
observed difference, but this difference was too slight and seemed not intriguing enough 
to warrant further investigation.    
Then, the question arose as to why replacement of Phe residues at positions of 267 or 
282 to Ser was effective in restoring the transport function of ΔNrPiC and ΔNhPiC 
expressed in yeast cells.  At this moment, we do not have any clear evidence that could 
explain such an elevation of this transport function.  The inevitable roles of a Ser 
residue at these positions for transport function of the PiC could be excluded, because 
the amino acids in yPiC corresponding to the Phe residues at positions of 267 and 282 
in mammalian PiC are not Ser ones (Fig. 1c).  Furthermore, reverse substitution of 
P274 or G289 of yPiC, corresponding to F267 or F282 of ΔNrPiC or ΔNhPiC, 
respectively, with Phe did not affect the growth of the host cells (Fig. 6a).  However, 
proper interpretation of this result would be difficult, because the amino acid sequence 
of PiC is not highly conserved between yeast and mammals.  The difference in 
phospholipid composition between mammalian and yeast mitochondria [34,35] might 
be a possible reason, because it is well known that certain phospholipids interact with 
mitochondrial solute carriers or are essential for their function [36,37].  This 
interpretation would be reasonable, because these two Phe residues in PiC identified in 
the present study have been estimated to be located at the putative 6th transmembrane 
region and to face the phospholipid phase rather than the internal cavity of the carrier 
[38].  In addition, the results of our substitution study on F282 in ΔNrPiC with several 
amino acids (Fig. 6b) also accord with this interpretation.  However, to ascertain the 
validity of this interpretation, further studies such as reconstitution experiments would 
be necessary.   
In the present study, we did not examine whether the expressed protein was properly 
localized at the mitochondrial inner membrane, but just dealt with it as “expressed well 
in the mitochondria”.  However, in an exact sense, we should also examine the sub 
mitochondrial localization of the expressed protein, as well as the effects of a point 
mutation (F/S) on it.   
In summary, we explored the factors required for functional expression of the 
mammalian mitochondrial phosphate carrier in yeast mitochondria.  The depletion of 
the presequence was effective for expression of mammalian PiC proteins in yeast 
15 
 
mitochondria, but further substitution of F267 or F282 with Ser was necessary for their 
functionality.  The results obtained in this study are important for further investigation 
of the mitochondrial phosphate carrier in mammals.   
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Fig. 1.  Structural features of the gene encoding mammalian PiC and its mRNA, 
N-terminal amino acid sequences of proteins for expression in yeast mitochondria 
examined in the present study, and comparison of the amino acid sequences of rat 
and human PiCs.   
Panel a, Organization of the gene encoding mammalian PiC.  The gene consists of 8 
exons, and two splice variants (PiC-A and -B) are formed by alternative use of one of 
these exons, 3A or 3B.  Panel b, Amino acid sequences of the N-terminal region of 
proteins used for expression in yeast mitochondria examined in the present study.  
Panel c, Comparison of the amino acid sequences of rat and human PiCs.  The amino 
acid sequences of the two splice variants of rat PiC (rPiC-A and rPiC-B) and of human 
PiC (hPiC-A and hPiC-B) are cited from NM_001270788.1 (rPiC-A), NM_139100.2 
(rPiC-B), NM_005888.3 (hPiC-A), and NM_002635.3 (hPiC-B), respectively; and their 
homology alignment was achieved by using the GENETYX program (GENETYX 
Corporation, Tokyo).  Numbers in the left and right margins represent the amino acid 
numbers counted with the N-terminal Ala residue in the mature protein taken as +1 [18].  
The amino acid residues perfectly conserved among the 4 sequences are indicated by 
asterisks.  The two broken perpendicular lines indicate the borders of amino acid 
sequences encoded by the alternative third exons, and the N-terminal presequences are 
highlighted by the box.  The two Phe (F) residues found to be critical for lack of 
functional expression of rPiC-A in yeast mitochondria, and corresponding human 
residues, are highlighted in blue.  The amino acid sequence of the C-terminal region of 
yPiC (NM_001181735) is given on the bottom line to show that these two Phe residues 
are not conserved in yeast.   
 
Fig. 2.  Effects of introduction of expression vectors into yeast cells lacking 
functional MIR1 gene (mir1Δ) on their growth on a glycerol plate, and expression 
analysis of various PiCs in yeast mitochondria   
Panel a, Culture suspensions of yeast cells lacking a functional MIR1 gene (mir1Δ) and 
transformants of the mir1Δ strain with a multi-copy type (pYO326) expression vector 
for yPiC, rPiC-A, ΔNrPiC-A, rPiC-B or ΔNrPiC-B were streaked onto a YPD or YPGly 
plate.  After incubation at 30° C for 2 or 3 days, cell growth on the plates was 
evaluated from photographs.  Panel b, Mitochondria fractions were prepared from the 
mir1Δ strain transformed with the indicated individual expression vectors.  Samples of 
20-μg (for detection of FLAG-tagged PiC) or 5-μg (for Por1p) aliquots of mitochondrial 
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proteins were subjected to SDS-PAGE and subsequent Western analysis with 
anti-FLAG (for detection of PiC having FLAG tag) or Por1p (control experiment) 
antibodies.   
 
Fig. 3.  Growth properties of yeast cells expressing rPiC and its mutants, and 
evaluation of their expression levels  
Panel a, Observation of the growth of yeast cells transformed with various expression 
vectors.  Culture suspensions of yeast cells lacking a functional MIR1 gene (mir1Δ) 
and transformants of the mir1Δ strain produced with the multi-copy type (pYO326) 
expression vector for yPiC, rPiC-A, ΔNrPiC-A, F267S or F282S were streaked onto a 
YPD or YPGly plate.  After incubation at 30° C for 2 (YPD plate) or 5 days (YPGly 
plate), cell growth on the plates was evaluated from photographs.  Panel b, For 
evaluation of the growth rates of individual yeast cells, culture suspensions of yeast 
cells were diluted with sufficient amounts of water to obtain an optical density at 600 
nm of 1, 0.1 or 0.01, spotted onto a YPD or YPGly plate, and incubated for 2 or 3 days.  
Panel c, For evaluation of the expression levels of rPiC-A, ΔNrPiC-A, ΔNrPiC (F267S), 
and ΔNrPiC (F282S), expression vectors encoding FLAG-tagged proteins were 
prepared and used for transformation.  Mitochondrial fractions were prepared from 
individual cell lines, and samples of 20-μg (for detection of FLAG) or 5-μg (for Por1p) 
aliquots of proteins were subjected to SDS-PAGE and subsequent Western analysis with 
anti-FLAG or Por1p antibodies.  
 
Fig. 4.  Phosphate transport function of the PiCs expressed in yeast mitochondria   
Panel a, Phosphate transport function of the PiCs expressed in yeast mitochondria was 
assessed by measuring the time-dependent turbidity change in mitochondrial 
suspensions containing either 120 mM NH4Pi or 120 mM NH4Cl [23], and the obtained 
results are shown by solid lines or broken lines, respectively.  Mitochondrial fractions 
prepared from the mir1Δ strain or from the mir1Δ strain transformed with the expression 
vector of yPiC were used as negative and positive controls, respectively.  Panel b, 
Phosphate transport function of PiCs expressed in yeast mitochondria was also 
conducted by measuring  [
32
P]phosphate uptake.   
 
Fig. 5.  Growth properties of yeast cells expressing hPiC and of its mutants  
Experiments were performed as stated in the legend for Fig. 3b.   
 
Fig. 6.  Growth properties of yeast cells expressing mutant yPiC and ΔNrPiC  
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Panel a, Effects of the substitution of the amino acids in yPiC corresponding to F267 
and F282 of mammalian PiC (P274 and G289, respectively) with Phe on the growth of 
yeast cells were evaluated.  Panel b, Effects of the substitution of F282 of ΔNrPiC 
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